
Genevia Technologies is a privately held Finnish bioinformatics company founded in 2011 in Tampere, Finland. It provides bioinformatics as a service, specializing in omics data analysis including DNA sequencing, RNA sequencing, single-cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics, and metabolomics. The company serves academic research groups and large biotech companies across Scandinavia, Western Europe, and North America, focusing on biomedical and cancer research but also supporting molecular biology, microbiology, and other life sciences. Genevia differentiates itself by assembling expert teams of bioinformaticians, data scientists, software developers, and molecular biologists to deliver customizable, high-quality bioinformatics analyses rapidly and with excellent communication. Its business model is a bioinformatics contract research organization (CRO) providing expert services to life science researchers and companies.

Genevia Technologies is a privately held Finnish bioinformatics company founded in 2011 in Tampere, Finland. It provides bioinformatics as a service, specializing in omics data analysis including DNA sequencing, RNA sequencing, single-cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics, and metabolomics. The company serves academic research groups and large biotech companies across Scandinavia, Western Europe, and North America, focusing on biomedical and cancer research but also supporting molecular biology, microbiology, and other life sciences. Genevia differentiates itself by assembling expert teams of bioinformaticians, data scientists, software developers, and molecular biologists to deliver customizable, high-quality bioinformatics analyses rapidly and with excellent communication. Its business model is a bioinformatics contract research organization (CRO) providing expert services to life science researchers and companies.